share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.

輝瑞 | 4:持股變動聲明-高管 DAMICO JENNIFER B.
美股sec公告 ·  07/02 01:18
牛牛AI助理已提取核心訊息
Jennifer B. Damico, SVP & Controller of Pfizer Inc. (PFE), was reported to have engaged in a transaction involving the company's stock on June 28, 2024. The specific details of the transaction, including the number of shares, nature of shares, transaction price, and total value, were not disclosed in the announcement. The report did not provide information on the number of shares held by Damico after the transaction. The transaction was recorded at the corporate address in New York, NY.
Jennifer B. Damico, SVP & Controller of Pfizer Inc. (PFE), was reported to have engaged in a transaction involving the company's stock on June 28, 2024. The specific details of the transaction, including the number of shares, nature of shares, transaction price, and total value, were not disclosed in the announcement. The report did not provide information on the number of shares held by Damico after the transaction. The transaction was recorded at the corporate address in New York, NY.
Pfizer公司的高級副總裁兼控制器Jennifer B. Damico於2024年6月28日涉嫌進行了一項涉及該公司股票的交易。該公告未披露交易的具體細節,包括股份數量、股份性質、交易價格和總價值。報告未提供Damico在交易後持有的股份數量信息。該交易記錄在紐約市的公司地址中。
Pfizer公司的高級副總裁兼控制器Jennifer B. Damico於2024年6月28日涉嫌進行了一項涉及該公司股票的交易。該公告未披露交易的具體細節,包括股份數量、股份性質、交易價格和總價值。報告未提供Damico在交易後持有的股份數量信息。該交易記錄在紐約市的公司地址中。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。